Blueprint Medicines Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (31)

View All

Latest Posts

About This Stock More About This Stock
Chart Of The Day: Does Blueprint Medicines Have A Blueprint For Success?
Article By: Jim Van Meerten
Wednesday, December 13, 2023 12:07 PM EDT
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
In this article: BPMC
Read
What You Missed On Wall Street On Thursday - Friday, June 10
Article By: The Fly
Friday, June 10, 2022 7:23 AM EDT
Here are our top five lists with the news and calls moving stocks, that you better not have missed yesterday...
In this article: APO, CVS, DE, KSS, NIO, OXM, SIG, SMG, STT, TGT, WFC, FRG, FCEL, NVAX, FWRD, NXPI, TSLA, TTWO, META, FIVE, ZEN, BPMC, SFIX, BILI, HNST, DIDI, BASE, SKIL
Read
8 Stocks To Watch For Wednesday, Jan. 22
Article By: Benzinga
Wednesday, January 22, 2020 5:21 AM EDT
Wall Street expects Abbott Laboratories to report quarterly earnings at $0.95 per share on revenue of $8.26 billion before the opening bell.
In this article: BPMC, STLD, IBM, JNJ, ABT, TXN, BKR, NFLX
Read
Week In Review: Four China Biopharmas Announce $100+ Million Deals In First Week Of 2020
Article By: ChinaBio® Today
Saturday, January 11, 2020 4:11 PM EDT
Apollomics of Hangzhou announced a $189 million agreement to develop two GlycoMimetics novel E-selectin-based immunotherapies in China for leukemia. Apollomics will be responsible for developing uproleselan and GMI-1687.
In this article: LLY, GLYC, BPMC, ZLAB
Read
Week In Review: Hua Medicine Approved For $200 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, June 9, 2018 4:46 PM EDT
Hua Medicine, a Beijing biopharma, announced its IPO application was accepted by the Hong Kong exchange. According to rumors, the company hopes to raise $200 million in the offering.
In this article: BPMC
Read
All Posts

Latest Tweets for $BPMC

No tweets yet!

PARTNER HEADLINES